Jubiglim MV 1 Plus Tablet SR
Marketer
Jubilant Life Sciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Jubiglim MV 1 Plus Tablet SR
Diabetac-Comb 1 Plus Extended-Release tablets are antidiabetic medications, a combination therapy for adult type 2 diabetes. They help manage blood glucose. This medication should be taken with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medicine as prescribed, even if feeling well or with controlled blood sugar; unsupervised cessation can elevate blood glucose, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are crucial in diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular mealtimes and carry a readily available fast-acting glucose source, such as candy or juice. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Disclose any history of heart disease to your physician before starting this treatment. Pregnant or breastfeeding individuals should consult their doctor before use. Regular blood glucose monitoring is necessary; your doctor may also recommend blood tests to monitor blood cell counts and liver function.
Uses of Jubiglim MV 1 Plus Tablet SR
Managing type 2 diabetes
Major Benefits of Jubiglim MV 1 Plus Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Jubiglim MV 1 Plus Tablet SR whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.
Common Side effects of Jubiglim MV 1 Plus Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Jubiglim MV 1 Plus Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Jubiglim MV 1 Plus Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Jubiglim MV 1 Plus Tablet SR works:
Jubiglim MV 1 Plus sustained-release tablets contain a triple combination of anti-diabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Jubiglim MV 1 Plus Tablet SR and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Jubiglim MV 1 Plus Tablet SR during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against these risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Jubiglim MV 1 Plus Tablet SR while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer into breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Jubiglim MV 1 Plus Tablet SR, as its use may be unsafe. A physician's consultation is advised. The use of Jubiglim MV 1 Plus Tablet SR is contraindicated in individuals with severe kidney impairment.
LiverCAUTION
Exercise caution when prescribing Jubiglim MV 1 Plus Tablet SR to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. A reduced initial dose of Jubiglim MV 1 Plus Tablet SR is typically recommended for patients experiencing mild to moderate liver dysfunction; its use is contraindicated in those with severe liver disease.
What if you forget to take Jubiglim MV 1 Plus Tablet SR :
Should you forget a dose of Jubiglim MV 1 Plus Tablet SR, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Jubiglim MV 1 Plus Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |



